Journal Article Summary
The article investigates the prevalence and incidence of dyskalemia, which refers to abnormal potassium levels in the blood, in adults with hypertension in Bangladesh before and after starting a fixed-dose combination (FDC) of telmisartan and amlodipine. This topic is significant because hypertension affects a large number of people globally, particularly in low- and middle-income countries, where access to healthcare resources, including laboratory testing, can be limited. The study aims to determine whether routine blood tests for potassium levels are necessary when initiating treatment with these medications, as the need for such tests may hinder effective hypertension management in resource-constrained settings.
The researchers conducted a community-based screening program in Dhaka, Bangladesh, involving 1,073 adults with untreated hypertension. They found that the prevalence of hypokalemia (low potassium) was 1.6%, and hyperkalemia (high potassium) was 0.2% among participants before treatment. After starting the FDC, only 1.5% of patients developed hypokalemia, and there were no cases of hyperkalemia. The study also reported a significant reduction in blood pressure among participants, indicating that the FDC was effective in managing hypertension without a high risk of dyskalemia.
Despite its findings, the study has limitations, including its single-arm design, which does not allow for comparisons with a control group, and reliance on self-reported data for some outcomes, which may introduce bias. Patients should be aware that while the study suggests that monitoring potassium levels may not be necessary in all cases, individual health circumstances can vary. It is essential for readers to discuss any concerns about potassium levels or hypertension treatment with their healthcare providers, especially if they have pre-existing conditions that could affect potassium balance or kidney function.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Ishigami Junichi, Hasan Md. Mahmudul, Sarker Aruna, Nahar Sharmin, Shuvo Sibly Sadik, Ishraquzzaman Mir, Al Mamun Mohammad Abdullah, Kalimuddin Md., et al.. Dyskalemia Prior to and After Initiation of a Fixed Dose Combination of Telmisartan and Amlodipine in Adults with Hypertension in Bangladesh. Global Heart 2025. DOI: 10.5334/gh.1415. PMID: 40124766. PMCID: PMC11927674.
Featured Pill Pals Product
Amlodipine 10 mg Tablets --- 30 Count --- Ascend Pharma Labs --- Generic For Norvasc
Amlodipine 10 mg Tablets — 30 Count — Ascend Pharma Labs — Generic For Norvasc is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
